INCON Co., Ltd. 4
4 · ZyVersa Therapeutics, Inc. · Filed Dec 16, 2022
Insider Transaction Report
Form 4
INCON Co., Ltd.
10% Owner
Transactions
- Award
Warrant (right to buy)
2022-12-12+450,702→ 450,702 totalExercise: $6.90Exp: 2027-12-12→ Common Stock (450,702 underlying) - Award
Common Stock
2022-12-12+1,497,199→ 1,497,199 total
Footnotes (1)
- [F1]The warrant is immediately exercisable in full.